Olema Pharmaceuticals, which trades on the Nasdaq under the ticker OLMA, is working to advance treatments for breast cancer through its development pipeline. The stock’s after-hours decline reflects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback